Delivery Order SPE2DB22D3501-SPE2DB25FWU68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9ML) with a firm fixed price structure. The contract, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25, 6-month to 4-year formulation, 0.9ml) valued at $1,570.70, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of vaccine product to support federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,570.70 for Pfizer COVID-19 vaccines (2024-25 formulation, 0.9ml) with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order through its...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (0.9 mL) under contract 4567983925. This firm fixed-price delivery order, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25 formulation, 0.9 mL, Emergency Use Authorization) with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The U.S. Defense Logistics Agency awarded a $3,141.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9 mL) with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- This delivery order, valued at $1,570.70, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under an Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under a firm fixed-price contract with a ceiling value of $1,570.70. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,162.70 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pfizer COVID-19 vaccine doses. This contract, which has a completion date of February 9, 2024, was awarded on February 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will perform the work at its corporate office located in...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU68Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,100.15 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9mL) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's broader contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and other critical medical commodities. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen demonstrates capability to fulfill federal medical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |